Oxygenta Pharmaceutical Ltd.

Financial

	Oxygenta Pharma	Ambalal Sarabhai Ent	Syschem (India)
Operational Metrics
Financials
5 yr Average ROE	10.1 %	19.11 %	-15.43 %
5yr average Equity Multiplier	-1.22	2.07	5.54
5yr Average Asset Turnover Ratio	1.1	0.75	1.2
5yr Avg Net Profit Margin	-16.74 %	10.89 %	-1.1 %
Price to Book	0.0	1.77	2.68
P/E	0.0	19.4	122.86
5yr Avg Cash Conversion Cycle	-56.32 Days	-37.53 Days	2.82 Days
Inventory Days	94.46 Days	33.51 Days	86.99 Days
Days Receivable	80.66 Days	63.69 Days	74.65 Days
Days Payable	174.19 Days	147.98 Days	168.44 Days
5yr Average Interest Coverage Ratio	-3.11	9.88	8.6
5yr Avg ROCE	-80.86 %	24.01 %	-1.51 %
5yr Avg Operating Profit Margin	-18.99 %	5.29 %	1.15 %
5 yr average Debt to Equity	-1.55	0.32	0.49
5yr CAGR Net Profit	-9.68 %	-30.01 %	n/a
5yr Average Return on Assets	-10.42 %	8.69 %	-0.74 %
Shareholdings
Promoter Holding	57.95 %	31.35 %	56.71 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	45.62 %	0.59 %	34.93 %
Change in Mutual Fund Holding (3 Yrs)	-0.04 %	0.0	0.0

Business

	Oxygenta Pharma	Ambalal Sarabhai Ent	Syschem (India)
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals 100.0 Electronics 0	Product Wise Break-Up Pharmaceutical 63.13 Electronics 36.87	Product Wise Break-Up Pharmaceuticals 100.0 Electronics 0